Literature DB >> 2485586

Iron and infection: the clinical evidence.

S J Oppenheimer1.   

Abstract

Iron deficiency is prevalent in childhood in the developed and developing countries. Programs of presumptive therapy, mass supplementation and food fortification have been introduced in many countries. The unresolved debate over the interaction of iron and infection in the clinical setting prompts re-evaluation of these practices. Situations of iron overload are associated with increased susceptibility to certain infections, although the exact mechanisms may vary with the main pathology. Iron treatment has been associated with acute exacerbations of infection, in particular malaria. In most instances parenteral iron was used. In the neonate parenteral iron is associated with serious E. coli sepsis. In one country, with endemic malaria, parenteral iron was associated with increased rates of malaria and increased morbidity due to respiratory disease in infants. In contrast in non-malarious countries studies of oral iron supplementation have if anything shown a reduction in infectious morbidity. Methodological problems in the latter reports indicate the need for further controlled prospective studies with accurate morbidity recording if informed recommendations are to be made.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2485586     DOI: 10.1111/apa.1989.78.s361.53

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  13 in total

1.  Helen Mackay, another iron lady.

Authors:  D Stevens
Journal:  BMJ       Date:  1991-07-20

2.  Helen Mackay and anaemia in infancy--then and now.

Authors:  D Stevens
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

3.  Neonatal prevention of iron deficiency.

Authors:  A Pisacane
Journal:  BMJ       Date:  1996-01-20

4.  Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy.

Authors:  P Harrison; S S Marwah; R T Hughes; D Bareford
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

5.  The immune response in iron-deficient young children: effect of iron supplementation on cell-mediated immunity.

Authors:  H Thibault; P Galan; F Selz; P Preziosi; C Olivier; J Badoual; S Hercberg
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

6.  Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells.

Authors:  Kyle A Bauckman; Indira U Mysorekar
Journal:  Autophagy       Date:  2016-05-03       Impact factor: 16.016

7.  Iron chelators as therapeutic agents against Pneumocystis carinii.

Authors:  G A Weinberg
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

8.  Cooperative Metabolic Adaptations in the Host Can Favor Asymptomatic Infection and Select for Attenuated Virulence in an Enteric Pathogen.

Authors:  Karina K Sanchez; Grischa Y Chen; Alexandria M Palaferri Schieber; Samuel E Redford; Maxim N Shokhirev; Mathias Leblanc; Yujung M Lee; Janelle S Ayres
Journal:  Cell       Date:  2018-08-09       Impact factor: 41.582

Review 9.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.